Connect with us

Press Release

Lumino, lightening up the world of secure multi-party computation

Published

on

New digital era, new demand of security

With the advent of the era of big data, the leakage and abuse of personal privacy data are common, which not only disturbs the normal market order, but also seriously restricts the innovation and development of the digital economy. In recent years, many countries have carried out relevant legislation of digital economy and data governance, which makes the legal requirements of personal privacy data more rigorous, and the supervision system is becoming increasingly strict. The various online scenarios led by the Covid-19 not only bring convenience to our life, but also cause a lot of security demand of data protection

Therefore, the data producers, such as government agencies, operators, platforms, are constantly raising the legal standards of storage, transmission and transaction. It has brought a problem to the data owners: how can fully utilize the data resource endowment to create business profits and social value, meanwhile ensure that the data privacy is protected in accordance with supervision provisions? The real demand behind the problem is bound to give birth to new technologies. The combination of blockchain and secure multi-party computation provides a new solution for breaking the “data island”, ensuring data security and releasing data value.

Recently, as the leader in the global blockchain industry, PlatON has started a new journey in the construction of privacy computation infrastructure, launching the secure multi-party computation ceremony—— Lumino. Lumino aims to create system parameters in a decentralized way, which could help build a real community-based, open-source blockchain ecosystem and ensure the underlying security of the main network and the reliability of future digital applications.

The “chemical reaction” of blockchain and secure multi-party computation

To understand the essence of Lumino, we need to understand the blockchain and secure multi-party computation. Blockchain is a technical solution that does not rely on a third party and a network that stores, verifies, transmits and communicates through its own distributed nodes. The core problems it solves are network decentralization, data consistency and tamper-prevent. Secure multi-party computation is to solve the problem of privacy protection among a group of mutual distrusted participants. It should ensure the independence, correctness decentralization and do not disclose the data to other participants. Secure multi-party computation was firstly proposed by professor Yao Qizhi, who is a Chinese computer scientist and the winner of Turing prize. Since 2010, the development of executable general compiler makes its concept gradually well-known.

It can be seen that both blockchain and multi-party security computation are technologies dealing with data interaction between a group of participants according to specific rules. However, blockchain is mainly used to verify the correctness of the calculation, and the purpose is to achieve the consistent recognition of the results and prevent the results from being tampered with; the purpose of secure multi-party computation (MPC) is to get specific results in the case of data confidentiality, and emphasis on privacy protection in data share situation.

When secure multi-party computation encounters blockchain, the integration has become a technology trend that attracts much attention. Due to the different traits of blockchain and multi-party security computation, they are not exclusive and can complement each other. Blockchain can improve its ability of data confidentiality by using secure multi-party computation to adapt to complex environments; while secure multi-party computation can complete redundant computation with the help of blockchain to obtain verifiable and unique results.

The combination of MPC and blockchain is ultimately to meet the more complex and changeable real needs, especially for various environments of data exchange and sharing. For example, secure multi-party computation can realize key management in the blockchain wallet, and divide the management right of assets reasonably to reduce the risk of single key loss. It can also realize the cross-domain access of EHR data. Based on personal digital identity infrastructure, hospital A could apply for data access to hospital B by obtaining the patient’s authorization, which does not need directly return the patient’s medical record data. It would meet the dual goals of diagnosis needs and privacy protection.

New practice in privacy protection——PlatON & Lumino

Secure multi-party computation is essentially a solution for data security. It is consisted of cryptographic technologies such as obfuscation circuit, secret sharing, homomorphic encryption, etc. PlatON has already realized the layout in these fileds. The key to secure multi-party computation is to use zero knowledge proof to prove that there is no leakage, which is also the key to Lumino.

Most of the existing efficient zero-knowledge proof algorithms need to create system parameters in a centralized way, so the third party who creates the parameters may forge proofs to destroy the underlying security of the main network. Lumino aims to generate the system parameters of the zero-knowledge proof through secure multi-party computation. In this process, the parameters are generated by members altogether, so they will not be obtained or tampered by a single party. This also constitutes the cornerstone of the subsequent privacy protection application. Only when the activity held safely, the subsequent decentralized application will be more secure.

This ceremony is PlatON’s latest practice in the field of privacy protection, and Lumino’s goal is to link the world’s cryptographic geeks to build a global privacy computation infrastructure. In the future community-based and open-source blockchain ecosystem, every participant is an important node, and every participation will make the underlying network more secure. Therefore, this is not only an activity, but also a collective wisdom full of ritual sense. PlatON will also take this opportunity to realize the vision of building infrastructure in the digital era, and make every effort to be the best practitioner in the field of privacy security.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Atlas Reserve Precious Metals Launches Transparent Gold IRA and Silver IRA Platform for Retirement Investors

Published

on

Atlas Reserve Precious Metals LLC is a Wyoming-registered precious metals dealer focused on transparent pricing, physical delivery options, and secure depository storage for self-directed retirement investors. The company provides access to IRS-eligible bullion products, allocated storage solutions, and rollover support services for qualified retirement accounts, founded on the principle that physical gold and silver should be accessible, understandable, and fairly priced for Americans seeking to diversify their retirement portfolios with tangible assets.

Cheyenne, Wyoming, United States, 21st May 2026Atlas Reserve Precious Metals LLC, a Wyoming-registered precious metals dealer, has announced the official launch of its physical gold and silver bullion platform designed for self-directed Gold IRAs and Silver IRAs. The company provides access to IRS-eligible gold and silver coins and bars, supported by transparent spot-plus-premium pricing and allocated storage through U.S.-based depositories.

The platform was developed to provide a straightforward process for individuals seeking to include physical precious metals within self-directed retirement account structures. Atlas Reserve supports rollovers from eligible retirement accounts, including traditional IRAs, Roth IRAs, and 401(k) plans, with dedicated support throughout the account transfer process.

“Atlas Reserve gives American investors a simple, transparent way to allocate a portion of their 401(k) or IRA into physical precious metals”

said Diren Tercanoglu, Director and Founder of Atlas Reserve Precious Metals LLC. 

“IRS-eligible gold and silver bullion at true low markups, combined with secure allocated storage and the flexibility of physical delivery – that is the foundation of what Atlas Reserve offers. The goal is to make real, physical assets accessible without the high fees or complexity that have historically made Gold IRAs difficult for everyday investors.”

Gold IRA and Silver IRA Platform Features

Atlas Reserve provides IRS-approved gold and silver coins and bars eligible for self-directed retirement accounts. Pricing follows a transparent spot-plus-premium structure with no undisclosed fees, offering investors clear visibility into premiums and transaction costs. The platform supports seamless rollover processing from 401(k)s, traditional IRAs, Roth IRAs, and other qualified plans. Storage is fully allocated and insured through leading U.S. depositories, with physical delivery available for investors who prefer direct possession.

401(k) to Gold IRA Rollover Guide

To support investors navigating the rollover process, Atlas Reserve has published a free educational resource covering eligibility requirements, IRS rules, custodian selection, and step-by-step rollover procedures. The guide is available at:

https://atlasreserve.global/ira/rollover-guide

About Atlas Reserve Precious Metals LLC

Atlas Reserve Precious Metals LLC is a Wyoming-registered precious metals dealer focused on transparent pricing, physical delivery options, and secure depository storage for self-directed retirement investors. The company provides access to IRS-eligible bullion products, allocated storage solutions, and rollover support services for qualified retirement accounts, founded on the principle that physical gold and silver should be accessible, understandable, and fairly priced for Americans seeking to diversify their retirement portfolios with tangible assets.

Website: https://atlasreserve.global

 

PR distributed by crmoonboy (crmoon): https://t.me/crmoon

 

Media Contact

Organization: Atlas Reserve Precious Metals LLC

Contact Person: Diren Tercanoglu

Website: https://atlasreserve.global/

Email:
admin@atlasreserve.global

Contact Number: +13076224606

City: Cheyenne

State: Wyoming

Country:United States

Release id:45242

The post Atlas Reserve Precious Metals Launches Transparent Gold IRA and Silver IRA Platform for Retirement Investors appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Niihara International Announces Launch of Corp. Website and SEC Qualification of Reg. A Offering

Published

on

Niihara International, Inc. has launched a new corporate website and received SEC qualification of its Regulation A+ Tier 2 offering to support development and commercialization of therapies, including L‑glutamine for sickle cell disease and other unmet medical needs.

Irvine, California, United States, 21st May 2026– Niihara International, Inc. (“Niihara International” or the “Company”), today announced the launch of its new corporate website at www.niiharainternational.com and the qualification by the U.S. Securities and Exchange Commission (“SEC”) of the Company’s Regulation A+ Tier 2 offering of common stock. The Company is a pharmaceutical access company focused on expanding access to proven therapies for serious and underserved medical conditions.

The new website is designed to provide investors, patients, healthcare professionals, and other stakeholders with streamlined access to information about the Company’s business, product development plans, corporate governance and investor materials. The site features dedicated sections for corporate information, regulatory filings, and updates regarding Niihara International’s efforts to develop and commercialize innovative therapies, including its initial product candidate, a generic prescription-grade L‑glutamine oral powder for sickle cell disease. 

Niihara International’s Regulation A+ Tier 2 offering has been qualified by the SEC pursuant to the Company’s Offering Circular, which is available on the SEC’s EDGAR system. Under the qualified offering, the Company is offering shares of its common stock on a “best efforts” basis, with the proceeds intended to fund product development, clinical, regulatory and commercialization activities, as well as general corporate purposes. 

The Offering Circular and related information about the offering can be accessed by visiting the SEC’s website and searching for Niihara International, Inc. (CIK 0002062360) or via the Company’s own website via the link to its subscription portal provided below. Prospective investors are urged to carefully review the Offering Circular, including the section titled “Risk Factors,” and all other documents incorporated by reference before making any investment decision.

“This is an important milestone for Niihara International as we advance our strategy to develop and deliver therapies for patients with serious unmet medical needs,” said Founder and CEO Yutaka Niihara. “The launch of our new website and the qualification of our Regulation A+ Tier 2 offering provide a foundation to communicate more effectively with investors and partners as we seek to execute on our growth plans.” 

The securities described in the Offering Circular are being offered pursuant to Regulation A under the Securities Act of 1933, as amended. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offering of securities will be made only by means of the Offering Circular and related subscription materials.

About Niihara International, Inc.

Niihara International, Inc., incorporated in California in 2023, is a development-stage biopharmaceutical company focused on the development, commercialization and distribution of innovative therapies. The Company is also focused on expanding access to proven therapies for serious and underserved medical conditions.

 The Company’s initial product is a generic prescription-grade L‑glutamine oral powder designed to reduce acute complications associated with sickle cell disease in patients ages five years and older. For more information, please visit www.niiharainternational.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the Company’s business strategy, development plans, product candidates, potential markets, and the anticipated use of proceeds of the Regulation A+ Tier 2 offering. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including those described under “Risk Factors” in the Offering Circular and in other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release, and Niihara International, Inc. undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances after the date hereof. 

Offering Portal Administrator
Glass Box Law, Inc.
Offering Portal Website:  https://glassboxlaw.com/portal/niihara-international-inc

Advancing Access to Essential Therapies for Patients with Unmet Medical Needs

 

Media Contact

Organization: Niihara International, Inc.

Contact Person: Maurice Bethea

Website: https://niiharainternational.com/

Email:
mbethea@niiharainternational.com

City: Rolling Hills Estates

State: California

Country:United States

Release id:45263

The post Niihara International Announces Launch of Corp. Website and SEC Qualification of Reg. A Offering appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Baiyunshan Hanfang Pharmaceutical Releases Technical Progress on Industrial High-Purity Lipid Raw Materials

Published

on

This Enterprise Unveils Industrial High-Purity Lipid Raw Material Product Portfolio for Global Fine Chemical Clients

Guangzhou, Guangdong, China, 21st May 2026 – Guangzhou Hanfang Pharmaceutical Company Limited. (a subsidiary of Guangzhou Pharmaceutical Holdings Limited) today announced updates to its industrial lipid raw material product portfolio and global service upgrades. The company’s offerings include industrial high-purity egg yolk lecithin, medium-chain triglycerides, and soybean oil (general-purpose raw material), tailored to meet industrial production requirements across multiple regions. Adopting a comprehensive business model encompassing direct sales, distribution, custom processing, and technical support, the enterprise serves over 1,000 clients worldwide with a business network spanning more than 20 countries and regions, further expanding its global fine chemical supply chain footprint.

Core Product Portfolio and Technical Services

Guangzhou Baiyunshan Hanfang Pharmaceutical provides products and services tailored for industrial fine chemical enterprises and related industries:

  • Industrial High-Purity Lipid Raw Materials: Supplies industrial high-purity egg yolk lecithin, medium-chain triglycerides, and soybean oil (general-purpose raw material), serving as core components for emulsifiers, cosolvents, and industrial energy additive raw materials, complying with process standards for industrial production scenarios.
  • Customization and Technical Support: Delivers customized solutions for exclusive raw material formulation needs, including compliant adjustments to component ratios and performance parameters; the technical team provides end-to-end guidance on production process applications.
  • Comprehensive Business Model: Covers direct sales, authorized distribution, custom processing, and technical services, meeting diverse needs from standard orders to customized projects.

Global Compliance and Quality Standards

The enterprise has established operational and quality systems aligned with international fine chemical supply chain norms. Its production base in Conghua, Guangzhou, adopts fully controlled end-to-end processes to ensure consistent product quality. Products are sold across Asia, Europe, and other regions, with efficient delivery enabled by mature logistics channels.

Supply and Service Information

Products are available globally through the direct sales team and authorized distributors. Orders are accepted from industrial fine chemical enterprises and related manufacturers, with standard production lead times provided. Custom processing services are available for premium clients, alongside formulation technical consultations. Clients may inquire via the official website or regional sales representatives.

“We focus on ensuring the stability of the fine chemical supply chain, with deep expertise in the lipid raw material sector,” said Chen Shiqi, Project Manager at Guangzhou Baiyunshan Hanfang Pharmaceutical. “We are committed to delivering stable, reliable products and technical support to meet the evolving needs of our global clients.”

Industry Background and Strategic Direction

Industry data indicates sustained growth in global demand for high-quality industrial lipid raw materials, driven primarily by the expansion of global fine chemical production capacity and the need for supply chain resilience. As a member enterprise of Guangzhou Pharmaceutical Holdings Limited, Baiyunshan Hanfang closely follows trends in the fine chemical supply chain industry, focusing on product stability and global technical services to support the growth of clients worldwide.

Future Plans

Guangzhou Baiyunshan Hanfang Pharmaceutical will continue to increase investment in production capacity and product R&D, with plans to expand its global distribution network, upgrade technical service systems for international clients, and prioritize meeting the diverse production needs of core markets.

About Guangzhou Hanfang Pharmaceutical Company Limited

Founded in 1998 and headquartered in Guangzhou, Guangzhou Hanfang Pharmaceutical Company Limited employs more than 330 people across production, R&D, quality control, and administration. The enterprise specializes in industrial fine chemical raw materials, lipid raw materials, and supporting technical services, with products sold in over 20 countries and regions. It holds multiple patents for lipid processing technologies, with its Conghua production base serving as the core production hub. The enterprise’s mission is “stable supply, technical collaboration, empowering the global fine chemical industry.”
For more information, please visit the official website: https://www.byshanhanfang.com/

Media Contact

Organization: Guangzhou Hanfang Pharmaceutical Company Limited

Contact Person: Ms. Chen Shiqi

Website: https://www.byshanhanfang.com/

Email: Send Email

Contact Number: +8613427652966

Address:No. 8 Wenquan Avenue, Wenquan Town, Conghua District, Guangzhou Guangdong Province, P.R. China

City: Guangzhou

State: Guangdong

Country:China

Release id:45292

The post Baiyunshan Hanfang Pharmaceutical Releases Technical Progress on Industrial High-Purity Lipid Raw Materials appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST